Endothelial Dysfunction in Fabry Disease Is Related to Glycocalyx Degradation
Fabry disease (FD) is an X-linked multisystemic lysosomal storage disease due to a deficiency of α-galactosidase A (GLA/AGAL). Progressive cellular accumulation of the AGAL substrate globotriaosylceramide (Gb3) leads to endothelial dysfunction. Here, we analyzed endothelial function in vivo and in v...
Guardado en:
Autores principales: | Solvey Pollmann, David Scharnetzki, Dominique Manikowski, Malte Lenders, Eva Brand |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/496b45111a274907bee2fcb13ab63526 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effect of HIV‐1 Infection on Angiopoietin 1 and 2 Levels and Measures of Microvascular and Macrovascular Endothelial Dysfunction
por: Anjali B. Thakkar, et al.
Publicado: (2021) -
α-Galactosidase a Deficiency in Fabry Disease Leads to Extensive Dysregulated Cellular Signaling Pathways in Human Podocytes
por: Ulrich Jehn, et al.
Publicado: (2021) -
Fabry disease patient-reported outcome (FD-PRO) demonstrates robust measurement properties for assessing symptom severity in Fabry disease
por: Alaa Hamed, et al.
Publicado: (2021) -
Angiopoietin-2 is associated with metabolic syndrome in chronic kidney disease
por: Fan-Chi Chang, et al.
Publicado: (2021) -
Curcumin improves prostanoid ratio in diabetic mesenteric arteries associated with cyclooxygenase-2 and NF-κB suppression
por: Patumraj S, et al.
Publicado: (2010)